Chronic Lymphocytic Leukemia
📧 Sign up to get email alerts when something new happens for Chronic Lymphocytic Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-05-30Clinical Trial Update: Monoclonal Antibody in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [Phase 1]
A Phase 1 clinical trial evaluating a monoclonal antibody in relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lympho…
-
CLINICAL_TRIALS trial_result · 2013-05-22Clinical Trial Update: Study of MDX-1342 in Patients With Chronic Lymphocytic Leukemia (CLL) [Phase 1]
This entry notes the completion of a Phase 1 clinical trial evaluating MDX-1342 in patients with chronic lymphocytic leukemia.
-
CLINICAL_TRIALS trial_result · 2013-05-15Clinical Trial Update: Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): DNA Microarray Gene Expression Analysis [Phase 2]
Phase 2 study update analyzing DNA microarray gene expression in chronic lymphocytic leukemia and small lymphocytic lymphoma, with results p…
-
CLINICAL_TRIALS trial_result · 2013-05-14Clinical Trial Update: Bevacizumab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia [Phase 2]
A Phase 2 trial assessed bevacizumab in patients with relapsed or refractory chronic lymphocytic leukemia; results were posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-05-09Clinical Trial Update: Eradication of Residual Disease by Preemptive Immunointervention After Allogeneic Hematopoietic Stem Cells Transplantation in Chronic Lymphocytic Leukemia [Phase 2]
This document provides an update on a Phase 2 clinical trial evaluating preemptive immunointervention after allogeneic hematopoietic stem ce…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-04-16Clinical Trial Update: Efficacy and Safety Study of Bendamustine With or Without Rituximab in Chronic Lymphoproliferative Disorders
A completed study evaluating bendamustine with or without rituximab in chronic lymphoproliferative disorders, including chronic lymphocytic …
-
CLINICAL_TRIALS trial_result · 2013-04-05Clinical Trial Update: Bryostatin 1 in Treating Patients With Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia [Phase 2]
Phase 2 trial of Bryostatin-1 in relapsed non-Hodgkin lymphoma or chronic lymphocytic leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2013-03-19Clinical Trial Update: Sorafenib and Bortezomib in Treating Patients With Advanced Cancer [Phase 1]
A Phase 1 study to evaluate the combination of sorafenib and bortezomib in patients with advanced cancers, including refractory chronic lymp…
-
CLINICAL_TRIALS trial_result · 2013-03-05Clinical Trial Update: Fludarabine and Thalidomide in Treating Patients With Newly Diagnosed Chronic Lymphocytic Leukemia [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating the combination of fludarabine and thalidomide in newly diagnosed chronic lymphocytic leukemia has compl…
-
CLINICAL_TRIALS trial_result · 2013-03-04Clinical Trial Update: CFAR Study in Patients With Chronic Lymphocytic Leukemia [Phase 2]
Phase 2 CFAR study in patients with chronic lymphocytic leukemia has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2013-02-12Clinical Trial Update: Alvocidib in Patients With Previously Treated Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia Arising From Chronic Lymphocytic Leukemia (CLL) [Phase 2]
Phase 2 trial update of alvocidib in patients with chronic lymphocytic leukemia and prolymphocytic leukemia arising from chronic lymphocytic…
-
CLINICAL_TRIALS trial_result · 2013-02-08Clinical Trial Update: XK469R in Treating Patients With Refractory Hematologic Cancer [Phase 1]
Phase 1 trial update reporting initial safety and tolerability findings for XK469R in patients with refractory hematologic cancers.
-
CLINICAL_TRIALS trial_result · 2013-02-04Clinical Trial Update: Pentostatin and Rituximab in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia [Phase 2]
Phase 2 trial evaluating pentostatin and rituximab in patients with low-grade non-Hodgkin lymphoma or chronic lymphocytic leukemia has compl…
-
CLINICAL_TRIALS trial_result · 2013-02-01Clinical Trial Update: Arsenic Trioxide in Treating Patients With Relapsed or Refractory Lymphoma or Leukemia [NA]
A clinical trial evaluated arsenic trioxide in patients with relapsed or refractory lymphoma and leukemia; the study status is terminated.
-
CLINICAL_TRIALS trial_result · 2013-01-31Clinical Trial Update: Photodynamic Therapy in Treating Patients With Lymphoma or Chronic Lymphocytic Leukemia [Phase 2]
A Phase 2 clinical trial evaluating photodynamic therapy for patients with lymphoma or chronic lymphocytic leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: Perifosine in Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma [Phase 2]
This update reports the completion of a Phase 2 trial of perifosine in relapsed or refractory chronic lymphocytic leukemia and small lymphoc…
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: CCI-779 in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia [Phase 2]
Phase 2 study of temsirolimus (CCI-779) in relapsed or refractory chronic lymphocytic leukemia has been terminated. The study also involved …
-
CLINICAL_TRIALS trial_result · 2013-01-18Clinical Trial Update: Sodium Salicylate in Treating Patients With Advanced Myelodysplastic Syndrome, Acute Myelogenous Leukemia, or Chronic Lymphocytic Leukemia [Phase 1]
A Phase 1 trial evaluating sodium salicylate in patients with advanced myelodysplastic syndromes, acute myeloid leukemia, or chronic lymphoc…
-
CLINICAL_TRIALS trial_result · 2013-01-17Clinical Trial Update: Flavopiridol in Treating Patients With Chronic Lymphocytic Leukemia [Phase 2]
A Phase 2 trial evaluated flavopiridol in patients with chronic lymphocytic leukemia, and the study has completed.
-
CLINICAL_TRIALS trial_result · 2013-01-15Clinical Trial Update: AZD2171 in Treating Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia [Phase 2]
This clinical trial update notes the completion status of a Phase 2 study evaluating AZD2171 (cediranib) in patients with relapsed or refrac…
-
CLINICAL_TRIALS trial_result · 2013-01-11Clinical Trial Update: Bryostatin and Vincristine in B-Cell Malignancies [Phase 1]
Phase 1 trial evaluating Bryostatin-1 in combination with Vincristine in several recurrent or refractory B-cell malignancies; the study has …
-
CLINICAL_TRIALS trial_result · 2012-12-31Clinical Trial Update: Fludarabine, Cyclophosphamide, and Rituximab in Treating Patients Who Have Chronic Lymphocytic Leukemia [Phase 2]
Phase 2 trial results for the fludarabine, cyclophosphamide, and rituximab regimen in chronic lymphocytic leukemia have been completed and p…
-
CLINICAL_TRIALS trial_result · 2012-12-17Clinical Trial Update: Transplantation for Patients With Chronic Lymphocytic Leukemia [NA]
The entry reports the completion of a clinical trial investigating transplantation for patients with chronic lymphocytic leukemia.
-
CLINICAL_TRIALS trial_result · 2012-12-07Clinical Trial Update: Study of Parathyroid Hormone Following Sequential Cord Blood Transplantation From an Unrelated Donor [Phase 2]
Phase 2 study evaluating parathyroid hormone after sequential cord blood transplantation from an unrelated donor; the trial was terminated a…
-
CLINICAL_TRIALS trial_result · 2012-12-03Clinical Trial Update: Fludarabine, Rituximab, and Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia [Phase 2]
Phase 2 clinical trial evaluating the combination of fludarabine, rituximab, and alemtuzumab in patients with chronic lymphocytic leukemia h…